Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2011

View Archived Issues

New vaccine shows promise in several models of infection

Phase III data support safety of dextromethorphan hydrobromide/quinidine sulfate in MS

Trial confirms earlier results with PET imaging agent florbetaben (18F)

Ampio Pharmaceuticals presents data from first-in-human Ampion trial

New TRPV4 channel antagonists disclosed

Adventrx and FDA agree on pivotal ANX-514 trial

Anthera Pharmaceuticals completes enrollment in PEARL-SC trial

MOC-carboetomidate induces hypnosis without adrenocortical suppression

Subcutaneous and intravenous secukinumab formulations evaluated in plaque psoriasis

Novel vasopressin V1A receptor antagonists designed by Roche

New Wnt signaling inhibitors discovered in Germany

TopoTarget patents new nicotinamide phosphoribosyltransferase inhibitors

Marina Biotech presents novel nucleic acid complexes

Intellect Neurosciences initiates development of new platform technology for proteinopathies

KemPharm to develop first-in-class oral hydromorphone prodrug

New Toll-like receptor 2 agonists prepared by IRM

Researchers at Abbott claim novel inhibitors of Bcl-2

Alexza Pharmaceuticals submits MAA for Adasuve

Marshall Edwards and Ausio Pharmaceuticals enter licensing agreement for AUS-131

Neuralstem completes phase Ia trial of NSI-189 in major depressive disorder

MHRA clears MediGene's clinical formulation study of RhuDex

Gilead files NDA for antiretroviral Quad regimen

European indication of Prevenar 13 extended

European Commission extends Alimta approval

FDA clears Ventana's companion algorithm for image analysis in HER2-positive breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...